...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office

I am not sure if I did so correctly, but I just tried to post today's news release that RVX received Notice of Allowance from the United States Patent and Trademark Office for patent claims covering the use of apabetalone in combination with Rosuvastatin in the United States.   Great news!

Share
New Message
Please login to post a reply